← Home
§ Evidence

How we build it,
how we test it.

Glucose Republic is being built on a common spine with the regulated medical-device version that will follow. The product ships today as a wellness companion. The documentation behind it is being kept in sync with the codebase, so the transition into a cleared device is a maturation rather than a re-architecture.

63
documented requirements / DHF
70%
linked to test evidence
3
regulatory frameworks engaged
2026
accuracy validation in scope
§ Regulatory posture

Three frameworks, all in scope.

01

IEC 62304 — Software Lifecycle

In progress · Class B candidate

Software classification under IEC 62304 (medical-device software lifecycle) is under active analysis. GR:eat is currently treated as a Class B candidate — software whose failure or unsafe operation could lead to non-serious injury — and the development process is being aligned to the standard's lifecycle requirements (planning, requirements analysis, architectural design, integration testing, release).

02

ISO 14971 — Risk Management

Workstream open · hazard analysis scoped 2026

A formal hazard analysis and software risk control matrix per ISO 14971 is in scope for 2026. The current Design History File catalogues known gap areas — safety gating before prediction display, audit logging, consent evidence model, cybersecurity hardening — as inputs to the risk file. None are stable yet; all are tracked.

03

FDA Human Factors Engineering

In scope · per FDA 2016 guidance

Use-related risk analysis and a formative-then-summative human-factors plan per the FDA's Applying Human Factors and Usability Engineering to Medical Devices guidance (Feb 2016) is in scope. Critical tasks are being identified from the requirements set; validation testing protocol is in draft.

§ Documentation

The Design History File is alive.

The DHF is generated from and maintained alongside the code. Requirements have code anchors. Code has traceability rows. Tests have requirement references. Everything is version- controlled, reviewable, and current.

Reviewing the company? We will share the full evidence package under NDA.

GR:eat is provided today as a wellness companion and is not a substitute for medical advice. It is not yet a cleared medical device. The regulated version is in scope for 2026.